These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 384069

  • 21. Usefulness and limitations of saralasin, a partial competitive agonist of angioten II, for evaluating the renin and sodium factors in hypertensive patients.
    Case DB, Wallace JM, Keim HJ, Sealey JE, Laragh JH.
    Am J Med; 1976 May 31; 60(6):825-36. PubMed ID: 1020762
    [Abstract] [Full Text] [Related]

  • 22. Systemic hemodynamic and hormonal responses during angiotensin II blockade with saralasin.
    Roos JC, Geyskes GG, Boer P, Dorhout Mees EJ.
    J Cardiovasc Pharmacol; 1981 May 31; 3(5):1106-15. PubMed ID: 6168855
    [Abstract] [Full Text] [Related]

  • 23. Changes of hemodynamics and glomerular ultrafiltration in renal hypertension of rats.
    Schwietzer G, Gertz KH.
    Kidney Int; 1979 Feb 31; 15(2):134-43. PubMed ID: 513481
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Hypertension, the adrenal and the kidney: lessons from pharmacologic interruption of the renin-angiotensin system.
    Hollenberg NK, Williams GH.
    Adv Intern Med; 1980 Feb 31; 25():327-61. PubMed ID: 6153859
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Diagnostic and therapeutic significance of inhibitors of the renin-angiotensin system].
    Stumpe KO, Kolloch RE, Redlich B, Vetter H, Krück F.
    Verh Dtsch Ges Kreislaufforsch; 1977 Feb 31; 43():167-76. PubMed ID: 613561
    [No Abstract] [Full Text] [Related]

  • 28. A comparison of biological effects of three angiotensin II antagonists in sodium depleted hypertensive patients.
    Ogihara T, Nakamaru M, Higaki J, Hata T, Kumagai A, Kumahara Y.
    Med J Osaka Univ; 1983 Sep 31; 34(1-2):21-5. PubMed ID: 6366501
    [No Abstract] [Full Text] [Related]

  • 29. Saralasin and SQ 20881 : their effects on central nervous system norepinephrine.
    Martínez Seeber A, Fernández BE, Domínguez AE, Vidal NA.
    Arch Int Physiol Biochim; 1978 Feb 31; 86(1):175-8. PubMed ID: 80175
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Effect of saralasin on plasma aldosterone in hypertensive man.
    Brown RD, Tucker R, Tue K, Wisgerhof M, Salassa R.
    J Lab Clin Med; 1978 Mar 31; 91(3):473-9. PubMed ID: 627750
    [No Abstract] [Full Text] [Related]

  • 37. [Effects of saralasin on 20 hypertensive patients (author's transl)].
    Plaza de los Reyes M, Passalacqua W, Plaza de los Reyes X, Pla C, Campino C.
    Rev Med Chil; 1980 Feb 31; 108(2):115-20. PubMed ID: 7017869
    [No Abstract] [Full Text] [Related]

  • 38. Clinical pharmacology of angiotensin antagonists.
    Pettinger WA, Mitchell HC.
    Fed Proc; 1976 Nov 31; 35(13):2521-5. PubMed ID: 976494
    [Abstract] [Full Text] [Related]

  • 39. [Hemodynamic changes after angiotensin II blockade by saralasin (author's transl)].
    Liebau G, Beyer J, Larbig D, Schick K, Sekanina G, Hayduk K.
    Klin Wochenschr; 1977 Jul 01; 55(13):647-9. PubMed ID: 19645
    [Abstract] [Full Text] [Related]

  • 40. Effects of angiotensin II and 1-Sar-8-Ala-angiotensin II on the renal function in sodium-replete and -deplete dogs [proceedings].
    Lijnen PJ, Fagard RH, Amery AK.
    Arch Int Physiol Biochim; 1979 Feb 01; 87(1):193-4. PubMed ID: 92269
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.